{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T12:31:53Z","timestamp":1794313913839,"version":"4.9.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100008868","name":"Jiangsu Province Department of Science and Technology","doi-asserted-by":"publisher","award":["BM2023002"],"award-info":[{"award-number":["BM2023002"]}],"id":[{"id":"10.13039\/501100008868","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010855","name":"Jiangsu Province Department of Human Resources and Social Security","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010855","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82002971"],"award-info":[{"award-number":["82002971"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82330119"],"award-info":[{"award-number":["82330119"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82504583"],"award-info":[{"award-number":["82504583"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011360","name":"State Key Laboratory of Natural Medicines","doi-asserted-by":"publisher","award":["SKLNMZZ202309"],"award-info":[{"award-number":["SKLNMZZ202309"]}],"id":[{"id":"10.13039\/501100011360","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["BK20231015"],"award-info":[{"award-number":["BK20231015"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["7032300014"],"award-info":[{"award-number":["7032300014"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002857","name":"China Pharmaceutical University","doi-asserted-by":"publisher","award":["2632023GR25"],"award-info":[{"award-number":["2632023GR25"]}],"id":[{"id":"10.13039\/501100002857","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.ejmech.2025.118471","type":"journal-article","created":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T16:05:49Z","timestamp":1765037149000},"page":"118471","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Discovery of novel small molecule inhibitor targeting the tumor promoting effect of transcription factor PLAGL2"],"prefix":"10.1016","volume":"303","author":[{"given":"Yushi","family":"Ding","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingyu","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Congying","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenyan","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengkang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dayong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beiying","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menghan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2025.118471_bib1","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","article-title":"Hepatocellular carcinoma","volume":"7","author":"Llovet","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.ejmech.2025.118471_bib2","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ejmech.2025.118471_bib3","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/s41571-021-00514-z","article-title":"Planning for tomorrow: global cancer incidence and the role of prevention 2020-2070","volume":"18","author":"Soerjomataram","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.ejmech.2025.118471_bib4","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1177\/1403494817715400","article-title":"The global cancer burden and human development: a review","volume":"46","author":"Fidler","year":"2018","journal-title":"Scand J Public Health"},{"key":"10.1016\/j.ejmech.2025.118471_bib5","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/j.jhep.2022.03.037","article-title":"Interventional treatment of hepatocellular carcinoma","volume":"77","author":"Salem","year":"2022","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ejmech.2025.118471_bib6","doi-asserted-by":"crossref","first-page":"3501","DOI":"10.1200\/JCO.2012.44.5643","article-title":"Randomized, multicenter, open-label study of oxaliplatin plus fluorouracil\/leucovorin versus doxorubicin as palliative chemotherapy in patients with advanced hepatocellular carcinoma from Asia","volume":"31","author":"Qin","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejmech.2025.118471_bib7","doi-asserted-by":"crossref","first-page":"477","DOI":"10.2147\/JHC.S452120","article-title":"Efficacy and safety of HepaSphere drug-eluting bead transarterial chemoembolization combined with hepatic arterial infusion chemotherapy as the second-line treatment in advanced hepatocellular carcinoma","volume":"11","author":"Liu","year":"2024","journal-title":"J. Hepatocell. Carcinoma"},{"key":"10.1016\/j.ejmech.2025.118471_bib8","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/s41392-023-01604-3","article-title":"Combined FOLFOX4 with all-trans retinoic acid versus FOLFOX4 with placebo in treatment of advanced hepatocellular carcinoma with extrahepatic metastasis: a randomized, double-blind comparative study","volume":"8","author":"Sun","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.ejmech.2025.118471_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3350\/cmh.2023.0125","article-title":"Recent advances in the management of hepatocellular carcinoma","volume":"30","author":"Sankar","year":"2024","journal-title":"Clin. Mol. Hepatol."},{"key":"10.1016\/j.ejmech.2025.118471_bib10","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/s41586-023-06991-9","article-title":"Matrix viscoelasticity promotes liver cancer progression in the pre-cirrhotic liver","volume":"626","author":"Fan","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2025.118471_bib11","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/s41575-023-00818-8","article-title":"Hepatocellular carcinoma surveillance \u2014 utilization, barriers and the impact of changing aetiology","volume":"20","author":"Huang","year":"2023","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejmech.2025.118471_bib12","article-title":"Predictive and prognostic factors in HCC patients treated with sorafenib","volume":"55","author":"Brunetti","year":"2019","journal-title":"Medicina (Kaunas)"},{"key":"10.1016\/j.ejmech.2025.118471_bib13","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1200\/JCO.22.00392","article-title":"Lenvatinib combined with transarterial chemoembolization as first-line treatment for advanced hepatocellular carcinoma: a phase III, randomized clinical trial (LAUNCH)","volume":"41","author":"Peng","year":"2023","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejmech.2025.118471_bib14","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/s41392-020-00264-x","article-title":"Targeted therapy for hepatocellular carcinoma","volume":"5","author":"Huang","year":"2020","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.ejmech.2025.118471_bib15","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/s41571-018-0073-4","article-title":"Molecular therapies and precision medicine for hepatocellular carcinoma","volume":"15","author":"Llovet","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.ejmech.2025.118471_bib16","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/nrclinonc.2017.127","article-title":"Fusions in solid tumours: diagnostic strategies, targeted therapy, and acquired resistance","volume":"14","author":"Schram","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.ejmech.2025.118471_bib17","doi-asserted-by":"crossref","first-page":"741","DOI":"10.2147\/JHC.S285726","article-title":"Elucidating the molecular basis of sorafenib resistance in HCC: current findings and future directions","volume":"8","author":"Fornari","year":"2021","journal-title":"J. Hepatocell. Carcinoma"},{"key":"10.1016\/j.ejmech.2025.118471_bib18","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41571-021-00573-2","article-title":"Immunotherapies for hepatocellular carcinoma","volume":"19","author":"Llovet","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.ejmech.2025.118471_bib19","article-title":"Programmed cell death protein 1 (PD-1) and programmed cell death ligand 1 (PD-L1) immunotherapy: a promising breakthrough in cancer therapeutics","volume":"15","author":"Abaza","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.ejmech.2025.118471_bib20","doi-asserted-by":"crossref","first-page":"362","DOI":"10.3892\/mmr.2021.12001","article-title":"A combination of PD-1\/PD-L1 inhibitors: the prospect of overcoming the weakness of tumor immunotherapy","volume":"23","author":"Kong","year":"2021","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.ejmech.2025.118471_bib21","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/s41590-019-0416-z","article-title":"Humanized immune system mouse models: progress, challenges and opportunities","volume":"20","author":"Allen","year":"2019","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ejmech.2025.118471_bib22","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s12929-016-0269-9","article-title":"Zinc finger proteins in cancer progression","volume":"23","author":"Jen","year":"2016","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.ejmech.2025.118471_bib23","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/jcp.20835","article-title":"LOT1 (ZAC1\/PLAGL1) and its family members: mechanisms and functions","volume":"210","author":"Abdollahi","year":"2007","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.ejmech.2025.118471_bib24","first-page":"1510","article-title":"The tumorigenic diversity of the three PLAG family members is associated with different DNA binding capacities","volume":"62","author":"Hensen","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejmech.2025.118471_bib25","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.536","article-title":"Selenium sulfide disrupts the PLAGL2\/C-MET\/STAT3-induced resistance against mitochondrial apoptosis in hepatocellular carcinoma","volume":"11","author":"Yang","year":"2021","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.ejmech.2025.118471_bib26","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s13046-021-01868-z","article-title":"Long non-coding RNA MAPKAPK5-AS1\/PLAGL2\/HIF-1\u03b1 signaling loop promotes hepatocellular carcinoma progression","volume":"40","author":"Wang","year":"2021","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.ejmech.2025.118471_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105685","article-title":"2-Methoxyestradiol synergizes with Erlotinib to suppress hepatocellular carcinoma by disrupting the PLAGL2-EGFR-HIF-1\/2\u03b1 signaling loop","volume":"169","author":"Zheng","year":"2021","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejmech.2025.118471_bib28","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1002\/hep.31293","article-title":"PLAGL2-EGFR-HIF-1\/2\u03b1 signaling loop promotes HCC progression and erlotinib insensitivity","volume":"73","author":"Hu","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.ejmech.2025.118471_bib29","article-title":"High expression of PLAGL2 is associated with poor prognosis in high-grade glioma","volume":"12","author":"Wang","year":"2021","journal-title":"Front. Genet."},{"key":"10.1016\/j.ejmech.2025.118471_bib30","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.ccr.2010.03.020","article-title":"PLAGL2 regulates wnt signaling to impede differentiation in neural stem cells and gliomas","volume":"17","author":"Zheng","year":"2010","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ejmech.2025.118471_bib31","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.1182\/blood-2004-09-3630","article-title":"Plag1 and Plagl2 are oncogenes that induce acute myeloid leukemia in cooperation with Cbfb-MYH11","volume":"105","author":"Landrette","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.ejmech.2025.118471_bib32","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/leu.2010.301","article-title":"The transcription factor PlagL2 activates mpl transcription and signaling in hematopoietic progenitor and leukemia cells","volume":"25","author":"Landrette","year":"2011","journal-title":"Leukemia"},{"key":"10.1016\/j.ejmech.2025.118471_bib33","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1007\/s10620-020-06416-x","article-title":"Hsa-circRNA-103809 promotes hepatocellular carcinoma development via MicroRNA-1270\/PLAG1 like zinc finger 2 axis","volume":"66","author":"Cao","year":"2021","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.ejmech.2025.118471_bib34","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.cell.2017.07.029","article-title":"The PI3K pathway in human disease","volume":"170","author":"Fruman","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2025.118471_bib35","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1021\/acs.jmedchem.1c01982","article-title":"Synthesis of hemiprotonic phenanthroline-phenanthroline","volume":"65","author":"Zhao","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118471_bib36","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1158\/0008-5472.CAN-20-2426","article-title":"Inhibition of FGFR reactivates IFN\u03b3 signaling in tumor cells to enhance the combined antitumor activity of lenvatinib with Anti-PD-1 antibodies","volume":"82","author":"Adachi","year":"2022","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejmech.2025.118471_bib37","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1111\/cas.15719","article-title":"Lenvatinib enhances antitumor immunity by promoting the infiltration of TCF1+ CD8+ T cells in HCC via blocking VEGFR2","volume":"114","author":"Mei","year":"2023","journal-title":"Cancer Sci."},{"key":"10.1016\/j.ejmech.2025.118471_bib38","article-title":"Cell-cell contact and matrix adhesion promote \u03b1SMA expression during TGF\u03b21-induced epithelial-myofibroblast transition via notch and MRTF-A","volume":"6","author":"O'Connor","year":"2016","journal-title":"Sci. Rep."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S022352342501236X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S022352342501236X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T04:43:57Z","timestamp":1781325837000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S022352342501236X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":38,"alternative-id":["S022352342501236X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118471","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of novel small molecule inhibitor targeting the tumor promoting effect of transcription factor PLAGL2","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118471","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118471"}}